Rogelio Manuel
Leira Muiño
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (8)
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
2020
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
2010
-
Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: How well are we correcting it?: Implications for outcome
Stroke, Vol. 41, Núm. 10, pp. 2362-2365
2009
-
The prognostic value of capillary glucose levels in acute stroke the GLycemia in acute stroke (GLIAS) study
Stroke, Vol. 40, Núm. 2, pp. 562-568
2003
-
Almotriptan versus rizatriptan in patients with migraine in Spain
Headache, Vol. 43, Núm. 7, pp. 734-741